AstraZeneca PLC (NYSE:AZN) was a big mover last session, as the company saw its shares rise a little above 9% on the day. The upside was driven after the company’s qannouncement of extremely encouraging results in a phase 3 trial by its candidate drugs. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 13% in the past one-month time frame.
The company has seen three positive estimate revisions in the past 30 days, while its Zacks Consensus Estimate moved higher over the same timeframe. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
AstraZeneca currently carries a Zacks Rank #3 (Hold).
Astrazeneca (LON:AZN) PLC Price
A top-ranked stock in the Large Cap Pharmaceuticals industry is Sanofi (NYSE:SNY) holding a Zacks Rank #2 (Buy). You can the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is AZN going up? Or down? Predict to see what others think: Up or Down
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>
Sanofi (SNY): Free Stock Analysis Report
Astrazeneca PLC (AZN): Free Stock Analysis Report
Original post
Zacks Investment Research